扶桑薬品工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/05/31 | 2,254 | 2,299 | 2,254 | 2,299 | +45 | +2% | 7,700 |
| 2024/05/30 | 2,242 | 2,255 | 2,227 | 2,254 | +12 | +0.5% | 8,400 |
| 2024/05/29 | 2,260 | 2,270 | 2,242 | 2,242 | -18 | -0.8% | 11,100 |
| 2024/05/28 | 2,277 | 2,287 | 2,260 | 2,260 | -18 | -0.8% | 4,800 |
| 2024/05/27 | 2,280 | 2,280 | 2,261 | 2,278 | -2 | -0.1% | 4,900 |
| 2024/05/24 | 2,266 | 2,283 | 2,254 | 2,280 | -5 | -0.2% | 6,300 |
| 2024/05/23 | 2,279 | 2,285 | 2,261 | 2,285 | +24 | +1.1% | 5,000 |
| 2024/05/22 | 2,269 | 2,277 | 2,261 | 2,261 | -2 | -0.1% | 10,300 |
| 2024/05/21 | 2,287 | 2,287 | 2,257 | 2,263 | -24 | -1% | 7,600 |
| 2024/05/20 | 2,273 | 2,300 | 2,273 | 2,287 | +14 | +0.6% | 13,200 |
| 2024/05/17 | 2,234 | 2,273 | 2,223 | 2,273 | +38 | +1.7% | 9,000 |
| 2024/05/16 | 2,287 | 2,287 | 2,226 | 2,235 | -18 | -0.8% | 8,500 |
| 2024/05/15 | 2,261 | 2,263 | 2,240 | 2,253 | -10 | -0.4% | 4,900 |
| 2024/05/14 | 2,293 | 2,293 | 2,241 | 2,263 | -21 | -0.9% | 9,800 |
| 2024/05/13 | 2,271 | 2,286 | 2,245 | 2,284 | +39 | +1.7% | 20,700 |
| 2024/05/10 | 2,236 | 2,335 | 2,163 | 2,245 | +32 | +1.4% | 51,600 |
| 2024/05/09 | 2,204 | 2,222 | 2,200 | 2,213 | +7 | +0.3% | 5,000 |
| 2024/05/08 | 2,214 | 2,245 | 2,200 | 2,206 | -15 | -0.7% | 4,300 |
| 2024/05/07 | 2,247 | 2,247 | 2,207 | 2,221 | +8 | +0.4% | 3,900 |
| 2024/05/02 | 2,244 | 2,244 | 2,210 | 2,213 | -34 | -1.5% | 5,400 |
| 2024/05/01 | 2,225 | 2,254 | 2,225 | 2,247 | +11 | +0.5% | 8,000 |
| 2024/04/30 | 2,229 | 2,239 | 2,213 | 2,236 | +25 | +1.1% | 10,100 |
| 2024/04/26 | 2,233 | 2,233 | 2,201 | 2,211 | -3 | -0.1% | 13,000 |
| 2024/04/25 | 2,231 | 2,233 | 2,208 | 2,214 | -17 | -0.8% | 8,400 |
| 2024/04/24 | 2,215 | 2,242 | 2,215 | 2,231 | +20 | +0.9% | 12,700 |
| 2024/04/23 | 2,240 | 2,240 | 2,209 | 2,211 | +3 | +0.1% | 3,700 |
| 2024/04/22 | 2,199 | 2,222 | 2,199 | 2,208 | +9 | +0.4% | 11,500 |
| 2024/04/19 | 2,233 | 2,233 | 2,163 | 2,199 | -34 | -1.5% | 18,600 |
| 2024/04/18 | 2,206 | 2,233 | 2,205 | 2,233 | +43 | +2% | 8,100 |
| 2024/04/17 | 2,242 | 2,242 | 2,190 | 2,190 | -16 | -0.7% | 9,000 |
| 2024/04/16 | 2,239 | 2,242 | 2,202 | 2,206 | -33 | -1.5% | 11,300 |
| 2024/04/15 | 2,223 | 2,239 | 2,222 | 2,239 | +1 | ±0% | 5,500 |
| 2024/04/12 | 2,248 | 2,248 | 2,218 | 2,238 | -8 | -0.4% | 13,000 |
| 2024/04/11 | 2,197 | 2,246 | 2,197 | 2,246 | +32 | +1.4% | 11,200 |
| 2024/04/10 | 2,194 | 2,229 | 2,188 | 2,214 | +13 | +0.6% | 6,200 |
| 2024/04/09 | 2,177 | 2,217 | 2,177 | 2,201 | +15 | +0.7% | 8,100 |
| 2024/04/08 | 2,178 | 2,197 | 2,153 | 2,186 | +11 | +0.5% | 9,400 |
| 2024/04/05 | 2,148 | 2,177 | 2,140 | 2,175 | +11 | +0.5% | 7,900 |
| 2024/04/04 | 2,163 | 2,168 | 2,146 | 2,164 | +2 | +0.1% | 11,100 |
| 2024/04/03 | 2,126 | 2,169 | 2,126 | 2,162 | +20 | +0.9% | 14,900 |
| 2024/04/02 | 2,152 | 2,158 | 2,126 | 2,142 | -22 | -1% | 23,100 |
| 2024/04/01 | 2,201 | 2,201 | 2,164 | 2,164 | -37 | -1.7% | 12,300 |
| 2024/03/29 | 2,198 | 2,220 | 2,195 | 2,201 | +19 | +0.9% | 11,500 |
| 2024/03/28 | 2,324 | 2,324 | 2,181 | 2,182 | -176 | -7.5% | 42,600 |
| 2024/03/27 | 2,350 | 2,363 | 2,338 | 2,358 | +14 | +0.6% | 124,300 |
| 2024/03/26 | 2,309 | 2,344 | 2,309 | 2,344 | +25 | +1.1% | 16,900 |
| 2024/03/25 | 2,320 | 2,345 | 2,314 | 2,319 | -6 | -0.3% | 18,200 |
| 2024/03/22 | 2,332 | 2,342 | 2,317 | 2,325 | -7 | -0.3% | 13,300 |
| 2024/03/21 | 2,350 | 2,350 | 2,326 | 2,332 | +5 | +0.2% | 17,700 |
| 2024/03/19 | 2,317 | 2,334 | 2,303 | 2,327 | +7 | +0.3% | 28,800 |
301～
350
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「扶桑薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 扶桑薬 | 220,000円 | +1.6% | -12.7% | 4.09% | 8.17倍 | 0.57倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| アンジェス | 8,200円 | +110.0% | - | 0.00% | - | 8.94倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
| ＣＡＮＢＡＳ | 119,700円 | - | - | 0.00% | - | 8.10倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| ステムリム | 31,300円 | - | - | 0.00% | - | 2.88倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| オンコリス | 70,800円 | +3771.0% | - | 0.00% | - | 12.34倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
市場注目の銘柄
チャート関連のコラム
